Drug Research
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
Alexion, AstraZeneca’s Rare Disease group, has entered into an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an investigational human monoclonal...
News
Second Booster Up’s Antibodies Five Times- Israeli Study
According to Naftali Bennett, the Israeli Prime Minister, as per preliminary findings in an Israeli study, a fourth COVID-19 jab can shoot-up antibodies five...
News
Wealthy Fail The World By Not Providing COVID-19 Jab Access
As per Amnesty International, both Pharma companies, as well as wealthy states of the world, have failed miserably to ensure that everyone has equal...
News
Australia Injects $5.5 M To Heal Low Survival Breast Cancers
In a development that gives a big sigh of relief to the breast cancer fraternity, funding of a couple of clinical trials which could...
Press Releases
Synairgen announces global strategic partnership with Ashfield Engage
Synairgen plc, the respiratory company developing SNG001 (inhaled interferon-beta or IFN-beta) for the treatment of COVID-19 as potentially the first host-targeted, broad-spectrum antiviral treatment...
News
ICRA Sees Growth In Indian Pharma Industry By 9-11% In FY22
Driven by the push from emerging as well as domestic markets in the upcoming quarters, the Indian Pharma industry in the Financial Year-22 is...
News
Ashfield Engage, Alliance Medical and NHS partner to identify early-stage lung cancer
Ashfield Engage, part of UDG Healthcare, has partnered with Alliance Medical to forge a new collaboration delivering the Targeted Lung Health Check (TLHC) programme...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read